0001209191-18-001959.txt : 20180104
0001209191-18-001959.hdr.sgml : 20180104
20180104163130
ACCESSION NUMBER: 0001209191-18-001959
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180102
FILED AS OF DATE: 20180104
DATE AS OF CHANGE: 20180104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nayeem Sara M.
CENTRAL INDEX KEY: 0001709110
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38129
FILM NUMBER: 18510523
MAIL ADDRESS:
STREET 1: 5425 WISCONSIN AVENUE
STREET 2: SUITE 800
CITY: CHEVY CHASE
STATE: MD
ZIP: 20815
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mersana Therapeutics, Inc.
CENTRAL INDEX KEY: 0001442836
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-498-0020
MAIL ADDRESS:
STREET 1: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: MERSANA THERAPEUTICS INC
DATE OF NAME CHANGE: 20080813
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-02
0
0001442836
Mersana Therapeutics, Inc.
MRSN
0001709110
Nayeem Sara M.
1954 GREENSPRING DRIVE
SUITE 600
TIMONIUM
MD
21093
1
0
0
0
Stock Option (right to buy)
17.39
2018-01-02
4
A
0
3560
0.00
A
2028-01-02
Common Stock
3560
3560
D
The option becomes exercisable in equal quarterly installments on the last day of each calendar quarter of 2018.
/s/ Sasha Keough, attorney-in-fact
2018-01-04